OC-0573: Improvement in late dysphagia following clinical target volume reduction in the De-ESCALaTE study

Autor: Mehmet Sen, M. Dalby, Hisham Mehanna, H. Al Booz, Janet A. Dunn, Christopher M. Nutting, Paul Sanghera, L. O'Toole, H. Yang, T. Fulton-Lieuw, Tom Roques, Charles Fong, B. Foran, Pankaj Mistry, Ann L. Hartley, M. Evans

Publikováno v: Radiotherapy and Oncology. 152:S320-S321

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2e010a1a08e42001d0f014feb8a4708f
https://doi.org/10.1016/s0167-8140(21)00595-8

Cetuximab versus cisplatin in patients with HPV-positive, low risk oropharyngeal cancer, receiving radical radiotherapy

Autor: E. Aynsley, A. Kong, D. Srinivasan, S. Brennan, Bernadette Foran, Laurence J. O'Toole, H. Al Booz, Hisham Mehanna, Janet A. Dunn, Max Robinson, Mehmet Sen, M. Dalby, Pankaj Mistry, K. Dyker, Rafael Moleron, T. Fulton-Lieuw, Alastair Gray, Andrew Hartley, A.K. Chan, Jan Buter

Publikováno v: Mehanna, H, Kong, A, Hartley, A, Mistry, P, Dalby, M, Fulton-Lieuw, T, Robinson, M, Gray, A, Foran, B, Sen, M, O'Toole, L, Dyker, K, Al Booz, H, Moleron, R, Brennan, S, Aynsley, E, Chan, A, Srinivasan, D, Buter, J & Dunn, J 2018, ' Cetuximab versus cisplatin in patients with HPV-positive, low risk oropharyngeal cancer, receiving radical radiotherapy ', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii729-viii730 . https://doi.org/10.1093/annonc/mdy424.046
Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii729-viii730. Oxford University Press

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcfb8ca2ac9e9743e9f83d424689be71
http://www.scopus.com/inward/record.url?scp=85081529081&partnerID=8YFLogxK

Phase III randomised controlled trial (RCT) comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer (CompARE)

Autor: Piers Gaunt, Hisham Mehanna, Andrew G. J. Hartley, Martin Forster, Sarah Bowden, Claire Gaunt, Max Robinson, Charlotte Firth, H. Al-Booz, Paul Sanghera, Elizabeth Miles, John D. Chester, Mehmet Sen, Marcus Jepson, Vinidh Paleri, Bernadette Foran, Anthony Hee Kong, Christina Yap, Jenny Donnovan, Jaspreet Babrah

Publikováno v: Journal of Clinical Oncology. 35:TPS6091-TPS6091

TPS6091 Background: Patients with intermediate and high-risk oropharyngeal cancer (OPC) have poorer response to standard treatment and poorer overall survival compared to low-risk OPC. The CompARE trial is designed to test alternative approaches to i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4116df89cbbf199011df9a197bfe448d
https://doi.org/10.1200/jco.2017.35.15_suppl.tps6091

11LBA Differences in the quality of life (QoL) and functional outcomes of treatment between HPV associated (HPV+) and HPV- patients receiving primary chemoradiotherapy in PET-NECK - a multi-centre randomized phase III controlled trial (RCT) comparing PETCT guided active surveillance with planned neck dissection (ND) for locally advanced (N2/N3) nodal metastases (LANM) in patients with head and neck squamous cell cancer (HNC) treated with primary radical chemoradiotherapy (CRT)

Autor: H. Mehanna, W.L. Wong, C.C. McConkey, J.K. Rahman, M. Robinson, A. Hartley, C. Nutting, N. Powell, H. Al-Booz, E. Junor, C. Hulme, A.F. Smith, P. Hall, J.A. Dunn

Publikováno v: European Journal of Cancer. 51:S715

11LBA LATE-BREAKING ABSTRACT Differences in the quality of life (QoL) and functional outcomes of treatment between HPV associated (HPV+) and HPV− patients receiving primary chemoradiotherapy in PET-NECK − a multi-centre randomized phase III contr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1cee9de52cc62c7c6645b434b972ec43
https://doi.org/10.1016/s0959-8049(16)31936-0

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.